273 related articles for article (PubMed ID: 2833347)
1. Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines.
Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin RH; Kidwell WR; Salomon DS
Cancer Res; 1988 May; 48(9):2483-91. PubMed ID: 2833347
[TBL] [Abstract][Full Text] [Related]
2. Differential growth factor expression in transformed mouse NIH-3T3 cells.
Ciardiello F; Valverius EM; Colucci-D'Amato GL; Kim N; Bassin RH; Salomon DS
J Cell Biochem; 1990 Jan; 42(1):45-57. PubMed ID: 1967612
[TBL] [Abstract][Full Text] [Related]
3. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional activity of transforming growth factor type beta on the growth of NRK-49F cells, normal and transformed by Kirsten murine sarcoma virus.
Jullien P; Berg TM; de Lannoy C; Lawrence DA
J Cell Physiol; 1988 Jul; 136(1):175-81. PubMed ID: 2840442
[TBL] [Abstract][Full Text] [Related]
5. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
6. Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta.
Nugent MA; Lane EA; Keski-Oja J; Moses HL; Newman MJ
Cancer Res; 1989 Jul; 49(14):3884-90. PubMed ID: 2786745
[TBL] [Abstract][Full Text] [Related]
7. Cell density and amino acid transport in 3T3, SV3T3, and SV3T3 revertant cells.
Borghetti AF; Piedimonte G; Tramacere M; Severini A; Ghiringhelli P; Guidotti GG
J Cell Physiol; 1980 Oct; 105(1):39-49. PubMed ID: 7430266
[TBL] [Abstract][Full Text] [Related]
8. Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
Yanagihara K; Ciardiello F; Talbot N; McGeady ML; Cooper H; Benade L; Salomon DS; Bassin RH
Oncogene; 1990 Aug; 5(8):1179-86. PubMed ID: 2202950
[TBL] [Abstract][Full Text] [Related]
9. Effect of phorbol esters on the activity of purified transforming growth factors.
Kraft AS
Cancer Res; 1986 Apr; 46(4 Pt 1):1764-7. PubMed ID: 3004705
[TBL] [Abstract][Full Text] [Related]
10. Induction of anchorage-independent growth by epidermal growth factor and altered sensitivity to type beta transforming growth factor in partially transformed rat kidney cells.
Newman MJ; Lane EA; Nugent MA; Racker E
Cancer Res; 1986 Nov; 46(11):5842-50. PubMed ID: 3019539
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
Serra R; Verderame MF; Isom HC
Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
[TBL] [Abstract][Full Text] [Related]
12. Infection with a TGF-alpha retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts.
McGeady ML; Kerby S; Shankar V; Ciardiello F; Salomon D; Seidman M
Oncogene; 1989 Nov; 4(11):1375-82. PubMed ID: 2812779
[TBL] [Abstract][Full Text] [Related]
13. Suppression of synthesis and utilization of tropomyosin in mouse and rat fibroblasts by transforming growth factor alpha: a pathway in oncogene action.
Cooper HL; Bhattacharya B; Bassin RH; Salomon DS
Cancer Res; 1987 Aug; 47(16):4493-500. PubMed ID: 3496963
[TBL] [Abstract][Full Text] [Related]
14. Orthovanadate both mimics and antagonizes the transforming growth factor beta action on normal rat kidney cells.
Rijksen G; Völler MC; Van Zoelen EJ
J Cell Physiol; 1993 Feb; 154(2):393-401. PubMed ID: 8425920
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
Liu C; Tsao MS; Grisham JW
Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture.
McMahon JB; Richards WL; del Campo AA; Song MK; Thorgeirsson SS
Cancer Res; 1986 Sep; 46(9):4665-71. PubMed ID: 3089593
[TBL] [Abstract][Full Text] [Related]
17. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
[TBL] [Abstract][Full Text] [Related]
18. Intracellular pH regulation in Hep G2 cells: effects of epidermal growth factor, transforming growth factor-alpha, and insulinlike growth factor-II on Na+/H+ exchange activity.
Strazzabosco M; Poci C; Spirlì C; Zsembery A; Granato A; Massimino ML; Crepaldi G
Hepatology; 1995 Aug; 22(2):588-97. PubMed ID: 7635429
[TBL] [Abstract][Full Text] [Related]
19. Transformation-restoring factor: a low molecular weight secreted factor required for anchorage-independent growth of oncogene-resistant mutant cell lines.
Yang JJ; Kang JS; Krauss RS
Oncogene; 1995 Apr; 10(7):1291-9. PubMed ID: 7731679
[TBL] [Abstract][Full Text] [Related]
20. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta.
Rizzino A; Ruff E; Rizzino H
Cancer Res; 1986 Jun; 46(6):2816-20. PubMed ID: 3457628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]